Cite
HARVARD Citation
Freshwater, D. et al. (n.d.). To Add or Not to Add: Would the Addition of Dalbavancin to Formulary Decrease Admissions for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)?. Open forum infectious diseases. pp. S337-S338. [Online].